Poseida Therapeutics, Inc. has raised $25.0M in total funding. The most recent round was Series A.
Poseida Therapeutics, Inc. is headquartered in San Diego, CA.
Poseida Therapeutics, a San Diego cell and gene therapy company founded by Eric Ostertag and once listed on Nasdaq as PSTX, was acquired by Roche in a December 2024 tender offer at $9.00/share cash plus a contingent value right.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.